<DOC>
	<DOCNO>NCT01629212</DOCNO>
	<brief_summary>The purpose study compare Efficacy Safety Tiropramide HCl Octylonium bromide Treatment Irritable Bowel Syndrome .</brief_summary>
	<brief_title>Comparison Efficacy Safety Tiropramide Octylonium Treatment Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiropramide</mesh_term>
	<mesh_term>Octylonium</mesh_term>
	<criteria>1 . Adult patient ( age 2075 year ) 2 . Patients suffer IBS define Rome III criteria 3 . Patients abdominal pain least 2 days/week , runin period 2 week 1 . Patients know intolerance tiropramide octylonium 2 . Patients uncontrolled diabetes , uncontrolled hypertension thyroid dysfunction 3 . Patients history cancer [ However , patient cancer gastrointerstinal cancer , recurr within 5 year treatment possible enrollment ] 4 . Patients hepatic renal dysfunction 5 . Patients lactose intorelance</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>